Literature DB >> 16096645

Acetylation of HIV-1 integrase by p300 regulates viral integration.

Anna Cereseto1, Lara Manganaro, Maria Ines Gutierrez, Mariaelena Terreni, Antonio Fittipaldi, Marina Lusic, Alessandro Marcello, Mauro Giacca.   

Abstract

Integration of HIV-1 into the human genome, which is catalyzed by the viral protein integrase (IN), preferentially occurs near transcriptionally active genes. Here we show that p300, a cellular acetyltransferase that regulates chromatin conformation through the acetylation of histones, also acetylates IN and controls its activity. We have found that p300 directly binds IN both in vitro and in the cells, as also specifically demonstrated by fluorescence resonance energy transfer technique analysis. This interaction results in the acetylation of three specific lysines (K264, K266, K273) in the carboxy-terminus of IN, a region that is required for DNA binding. Acetylation increases IN affinity to DNA, and promotes the DNA strand transfer activity of the protein. In the context of the viral replication cycle, point mutations in the IN acetylation sites abolish virus replication by specifically impairing its integration capacity. This is the first demonstration that HIV-1 IN activity is specifically regulated by post-translational modification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096645      PMCID: PMC1201351          DOI: 10.1038/sj.emboj.7600770

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

Review 1.  In vivo analysis of retroviral integrase structure and function.

Authors:  A Engelman
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  E2F family members are differentially regulated by reversible acetylation.

Authors:  G Marzio; C Wagener; M I Gutierrez; P Cartwright; K Helin; M Giacca
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

3.  In vitro human immunodeficiency virus type 1 integrase assays.

Authors:  C Marchand; N Neamati; Y Pommier
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

Review 4.  Acetylation of histones and transcription-related factors.

Authors:  D E Sterner; S L Berger
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

5.  Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target.

Authors:  S Carteau; C Hoffmann; F Bushman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

7.  HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF.

Authors:  O D Lau; T K Kundu; R E Soccio; S Ait-Si-Ali; E M Khalil; A Vassilev; A P Wolffe; Y Nakatani; R G Roeder; P A Cole
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

8.  Mapping DNA-binding sites of HIV-1 integrase by protein footprinting.

Authors:  A M Dirac; J Kjems
Journal:  Eur J Biochem       Date:  2001-02

9.  Characterization of the minimal DNA-binding domain of the HIV integrase protein.

Authors:  R A Lutzke; C Vink; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

10.  HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.

Authors:  G Marzio; M Tyagi; M I Gutierrez; M Giacca
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  76 in total

1.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

2.  A new functional role of HIV-1 integrase during uncoating of the viral core.

Authors:  Marisa S Briones; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

3.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes.

Authors:  Lara Manganaro; Marina Lusic; Maria Ines Gutierrez; Anna Cereseto; Giannino Del Sal; Mauro Giacca
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

5.  Prediction of Nepsilon-acetylation on internal lysines implemented in Bayesian Discriminant Method.

Authors:  Ao Li; Yu Xue; Changjiang Jin; Minghui Wang; Xuebiao Yao
Journal:  Biochem Biophys Res Commun       Date:  2006-10-02       Impact factor: 3.575

Review 6.  Metabolism, cytoskeleton and cellular signalling in the grip of protein Nepsilon - and O-acetylation.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  EMBO Rep       Date:  2007-06       Impact factor: 8.807

Review 7.  HIV integrase inhibitors: 20-year landmark and challenges.

Authors:  Mathieu Métifiot; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2013

Review 8.  The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis.

Authors:  Dongsheng Li; Ting Wei; Catherine M Abbott; David Harrich
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

9.  Ubiquitination of tombusvirus p33 replication protein plays a role in virus replication and binding to the host Vps23p ESCRT protein.

Authors:  Daniel Barajas; Peter D Nagy
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

Review 10.  Retroviral Integrase: Then and Now.

Authors:  Mark D Andrake; Anna Marie Skalka
Journal:  Annu Rev Virol       Date:  2015-11       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.